Variant report

Variant	nsv1064436
Chromosome Location	chr21:39846571-39875576
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:423)
CpG islands
(count:306)
Chromatin interactive
region (count:14)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:423 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr21:39848195-39848707	K562	blood:	n/a	n/a
2	ATF1	chr21:39850760-39850968	K562	blood:	n/a	n/a
3	BHLHE40	chr21:39850414-39850481	K562	blood:	n/a	chr21:39850418-39850431 chr21:39850419-39850428 chr21:39850420-39850429 chr21:39850414-39850435 chr21:39850420-39850429
4	BHLHE40	chr21:39848287-39848703	K562	blood:	n/a	n/a
5	BHLHE40	chr21:39850781-39851061	K562	blood:	n/a	n/a
6	CCNT2	chr21:39848176-39848738	K562	blood:	n/a	chr21:39848512-39848532
7	CEBPB	chr21:39848287-39848466	K562	blood:	n/a	n/a
8	CEBPB	chr21:39866840-39867060	H1-hESC	embryonic stem cell:	n/a	chr21:39866983-39867000
9	CEBPB	chr21:39857305-39857505	MCF-7	breast:	n/a	n/a
10	CEBPB	chr21:39857355-39857556	K562	blood:	n/a	n/a
11	CEBPB	chr21:39857412-39857503	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr21:39856469-39856684	K562	blood:	n/a	n/a
13	CEBPB	chr21:39857424-39857444	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr21:39860117-39860618	ECC-1	luminal epithelium:	n/a	chr21:39860176-39860184
15	CEBPB	chr21:39850866-39851035	K562	blood:	n/a	n/a
16	CEBPD	chr21:39848264-39848680	K562	blood:	n/a	n/a
17	CEBPD	chr21:39848230-39848766	K562	blood:	n/a	n/a
18	CTCF	chr21:39866696-39866832	MCF-7	breast:	n/a	n/a
19	CTCF	chr21:39866739-39866795	NHEK	skin:	n/a	n/a
20	CTCF	chr21:39866721-39866805	MCF-7	breast:	n/a	n/a
21	CTCF	chr21:39866720-39866870	RPTEC	kidney:	n/a	n/a
22	CTCF	chr21:39866713-39866814	MCF-7	breast:	n/a	n/a
23	CTCF	chr21:39866560-39866710	HCM	heart:	n/a	n/a
24	CTCF	chr21:39866620-39866770	HRE	kidney:	n/a	n/a
25	CTCF	chr21:39866680-39866830	HBMEC	blood vessel:	n/a	n/a
26	CTCF	chr21:39866663-39866866	Fibrobl	skin:	n/a	n/a
27	CTCF	chr21:39865820-39865970	HUVEC	blood vessel:	n/a	n/a
28	CTCF	chr21:39866670-39866854	ProgFib	skin:	n/a	n/a
29	CTCF	chr21:39866703-39866833	MCF-7	breast:	n/a	n/a
30	CTCF	chr21:39866460-39866610	HUVEC	blood vessel:	n/a	n/a
31	CTCF	chr21:39866737-39866845	Gliobla	brain:	n/a	n/a
32	CTCF	chr21:39866720-39866870	HUVEC	blood vessel:	n/a	n/a
33	CTCF	chr21:39862508-39862615	H1-hESC	embryonic stem cell:	n/a	n/a
34	CTCF	chr21:39866700-39866850	HMEC	breast:	n/a	n/a
35	CTCF	chr21:39866680-39866830	WERI-Rb-1	eye:	n/a	n/a
36	CTCF	chr21:39865800-39865950	HUVEC	blood vessel:	n/a	n/a
37	CTCF	chr21:39866620-39866770	RPTEC	kidney:	n/a	n/a
38	CTCF	chr21:39866720-39866870	HCPEpiC	choroid plexus:	n/a	n/a
39	CTCF	chr21:39862460-39862610	HUVEC	blood vessel:	n/a	n/a
40	CTCF	chr21:39866560-39866710	HAc	cerebellar:	n/a	n/a
41	CTCF	chr21:39862440-39862590	WERI-Rb-1	eye:	n/a	n/a
42	CTCF	chr21:39866640-39866790	HCPEpiC	choroid plexus:	n/a	n/a
43	CTCF	chr21:39866724-39866836	MCF-7	breast:	n/a	n/a
44	E2F4	chr21:39858257-39858491	MCF10A-Er-Src	breast:	n/a	n/a
45	E2F6	chr21:39847409-39847878	H1-hESC	embryonic stem cell:	n/a	n/a
46	EP300	chr21:39875230-39876172	SK-N-SH	brain:	n/a	chr21:39875597-39875604
47	EP300	chr21:39858115-39858736	ECC-1	luminal epithelium:	n/a	n/a
48	EP300	chr21:39859891-39860696	ECC-1	luminal epithelium:	n/a	n/a
49	EP300	chr21:39858069-39858677	SK-N-SH	brain:	n/a	n/a
50	EP300	chr21:39859970-39860808	ECC-1	luminal epithelium:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:39870627-39870677	LNCaP	prostate:	n/a
2	chr21:39870627-39870677	LNCaP	prostate:	n/a
3	chr21:39870397-39870447	MCF10A-Er-Src	breast:	n/a
4	chr21:39870627-39870677	HepG2	liver:	n/a
5	chr21:39871287-39871337	HCT-116	colon:	n/a
6	chr21:39871287-39871337	AG09319	gingival:	n/a
7	chr21:39870627-39870677	SKMC	muscle:	n/a
8	chr21:39871287-39871337	NB4	blood:	n/a
9	chr21:39870627-39870677	Hela-S3	cervix:	n/a
10	chr21:39870397-39870447	HAEpiC	amniotic membrane:	n/a
11	chr21:39871287-39871337	U87	brain:	n/a
12	chr21:39870627-39870677	HNPCEpiC	eye:	n/a
13	chr21:39871301-39871351	T-47D	breast:	n/a
14	chr21:39870704-39870754	SK-N-SH_RA	brain:	n/a
15	chr21:39870627-39870677	HEK293	kidney:	embryo
16	chr21:39870397-39870447	GM12891	blood:	n/a
17	chr21:39871301-39871351	IMR90	lung:	fetal
18	chr21:39871287-39871337	PANC-1	pancreas:	n/a
19	chr21:39870397-39870447	PrEC	prostate:	n/a
20	chr21:39871287-39871337	HMEC	breast:	n/a
21	chr21:39870397-39870447	GM19239	blood:	n/a
22	chr21:39870397-39870447	HRE	kidney:	n/a
23	chr21:39870627-39870677	HL-60	blood:	n/a
24	chr21:39871287-39871337	HCM	heart:	n/a
25	chr21:39870704-39870754	SAEC	small airway:	n/a
26	chr21:39871301-39871351	AG10803	skin:	n/a
27	chr21:39870704-39870754	Jurkat	blood:	n/a
28	chr21:39871301-39871351	HRE	kidney:	n/a
29	chr21:39870397-39870447	AG10803	skin:	n/a
30	chr21:39870397-39870447	HEK293	kidney:	embryo
31	chr21:39871287-39871337	AG04450	lung:	fetal
32	chr21:39870397-39870447	ProgFib	skin:	n/a
33	chr21:39870397-39870447	T-47D	breast:	n/a
34	chr21:39871287-39871337	A549	lung:	n/a
35	chr21:39870397-39870447	PANC-1	pancreas:	n/a
36	chr21:39870704-39870754	NH-A	brain:	n/a
37	chr21:39871287-39871337	Jurkat	blood:	n/a
38	chr21:39870704-39870754	HEEpiC	esophagus:	n/a
39	chr21:39871287-39871337	HRCEpiC	kidney:	n/a
40	chr21:39870627-39870677	GM12891	blood:	n/a
41	chr21:39870704-39870754	AoSMC	blood vessel:	n/a
42	chr21:39870397-39870447	AG09319	gingival:	n/a
43	chr21:39871287-39871337	BE2_C	brain:	n/a
44	chr21:39870704-39870754	NHBE	bronchial:	n/a
45	chr21:39870397-39870447	HCPEpiC	choroid plexus:	n/a
46	chr21:39870704-39870754	HMEC	breast:	n/a
47	chr21:39870704-39870754	AG04449	skin:	fetal
48	chr21:39871287-39871337	GM12891	blood:	n/a
49	chr21:39870704-39870754	SK-N-SH	brain:	n/a
50	chr21:39870704-39870754	A549	lung:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:39868583..39871033-chr21:39873297..39876116,2	K562	blood:
2	chr21:39868583..39871033-chr21:39873297..39876116,2	K562	blood:
3	chr21:39774988..39777692-chr21:39864933..39866829,2	MCF-7	breast:
4	chr21:39848201..39851847-chr21:39852141..39856874,4	K562	blood:
5	chr21:39844325..39848351-chr21:39848491..39850801,3	MCF-7	breast:
6	chr21:39868178..39870338-chr21:39876801..39879710,3	MCF-7	breast:
7	chr21:39866030..39869325-chr21:39869672..39873977,4	MCF-7	breast:
8	chr21:39838779..39841665-chr21:39845089..39847967,2	MCF-7	breast:
9	chr21:39848201..39851847-chr21:39852141..39856874,4	K562	blood:
10	chr21:39860012..39862527-chr21:39874873..39876788,2	MCF-7	breast:
11	chr21:39860012..39862527-chr21:39874873..39876788,2	MCF-7	breast:
12	chr21:39844325..39848351-chr21:39848491..39850801,3	MCF-7	breast:
13	chr21:39861096..39863150-chr21:39872187..39874379,2	K562	blood:
14	chr21:39840191..39842812-chr21:39847792..39850262,2	MCF-7	breast:

No data

Variant related genes	Relation type
ERG	TF binding region
SNRPGP13	TF binding region
ERG	CpG island
SNRPGP13	CpG island
ENSG00000157554	chromatin interactions
ENSG00000231480	chromatin interactions

Extended variants
information (count: 1076 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:1076 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185888339	chr21:39846602-39846603	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs563333462	chr21:39846619-39846620	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs5843909	chr21:39846655-39846656	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs372144520	chr21:39846666-39846667	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs397759400	chr21:39846667-39846668	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs35479414	chr21:39846685-39846686	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs9978004	chr21:39846695-39846696	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs552711890	chr21:39846713-39846714	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs566123070	chr21:39846727-39846728	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs535365010	chr21:39846770-39846771	Weak transcription Bivalent Enhancer Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs142902849	chr21:39846805-39846806	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs568441663	chr21:39846832-39846833	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs537006624	chr21:39846842-39846843	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs557048378	chr21:39846852-39846853	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs576897144	chr21:39846858-39846859	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs539523987	chr21:39846872-39846873	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs558751164	chr21:39846878-39846879	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs568331985	chr21:39846891-39846892	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs188256503	chr21:39846934-39846935	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs180996195	chr21:39847043-39847044	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
21	rs75497364	chr21:39847044-39847045	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
22	rs574495526	chr21:39847045-39847046	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
23	rs543410002	chr21:39847048-39847049	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
24	rs566922242	chr21:39847052-39847053	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
25	rs563396820	chr21:39847069-39847070	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
26	rs532275471	chr21:39847082-39847083	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
27	rs534417727	chr21:39847120-39847121	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
28	rs551973140	chr21:39847127-39847128	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
29	rs559939134	chr21:39847149-39847150	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
30	rs528629206	chr21:39847166-39847167	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
31	rs548869338	chr21:39847202-39847203	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs186369931	chr21:39847246-39847247	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs114236657	chr21:39847279-39847280	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs550589442	chr21:39847293-39847294	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs192183633	chr21:39847340-39847341	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs539585314	chr21:39847350-39847351	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs557331748	chr21:39847357-39847358	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs150789055	chr21:39847494-39847495	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs577615590	chr21:39847516-39847517	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs2070351	chr21:39847562-39847563	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs11701454	chr21:39847563-39847564	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs577933430	chr21:39847576-39847577	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
43	rs543720370	chr21:39847590-39847591	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
44	rs557032523	chr21:39847596-39847597	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
45	rs116927463	chr21:39847616-39847617	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs80293768	chr21:39847633-39847634	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs545883921	chr21:39847680-39847681	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs183958013	chr21:39847715-39847716	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs528697662	chr21:39847716-39847717	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs542028208	chr21:39847725-39847726	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21364760	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Acute myeloid leukemia	17237825	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Down syndrome	20877625	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Prostate cancer	21147910	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Prostate cancer	20562851	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:788 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:39811200-39847400	Weak transcription	Right Ventricle	heart
2	chr21:39843400-39855200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
3	chr21:39843400-39858200	Weak transcription	Esophagus	oesophagus
4	chr21:39844200-39847000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
5	chr21:39844200-39847200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr21:39844200-39847200	Weak transcription	NHEK	skin
7	chr21:39844400-39847200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr21:39844800-39847600	Weak transcription	HUES48 Cell Line	embryonic stem cell
9	chr21:39845000-39847000	Genic enhancers	Primary hematopoietic stem cells	blood
10	chr21:39845000-39847400	Weak transcription	Left Ventricle	heart
11	chr21:39845000-39848200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr21:39845000-39849000	Weak transcription	Right Atrium	heart
13	chr21:39845200-39847000	Genic enhancers	Primary hematopoietic stem cells short term culture	blood
14	chr21:39845200-39848000	Enhancers	Primary monocytes fromperipheralblood	blood
15	chr21:39845200-39848000	Enhancers	Primary neutrophils fromperipheralblood	blood
16	chr21:39845400-39847000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
17	chr21:39845600-39846800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
18	chr21:39845800-39846600	Enhancers	ES-I3 Cell Line	embryonic stem cell
19	chr21:39845800-39846600	Enhancers	Hela-S3	cervix
20	chr21:39845800-39846600	Flanking Active TSS	HUVEC	blood vessel
21	chr21:39845800-39847400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
22	chr21:39845800-39848200	Enhancers	Fetal Thymus	thymus
23	chr21:39846000-39846600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
24	chr21:39846000-39846600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr21:39846000-39847800	Enhancers	HMEC	breast
26	chr21:39846200-39846600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
27	chr21:39846200-39847000	Enhancers	Placenta	Placenta
28	chr21:39846200-39847200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr21:39846200-39847800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr21:39846200-39848000	Enhancers	Spleen	Spleen
31	chr21:39846400-39846600	Enhancers	Osteobl	bone
32	chr21:39846400-39846800	Weak transcription	Thymus	Thymus
33	chr21:39846400-39847000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr21:39846400-39847400	Weak transcription	H1 Cell Line	embryonic stem cell
35	chr21:39846400-39847400	Weak transcription	HUES6 Cell Line	embryonic stem cell
36	chr21:39846400-39847400	Weak transcription	Aorta	Aorta
37	chr21:39846400-39847600	Weak transcription	Fetal Heart	heart
38	chr21:39846400-39847800	Enhancers	Monocytes-CD14+_RO01746	blood
39	chr21:39846400-39849000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
40	chr21:39846400-39855600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr21:39846400-39855800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
42	chr21:39846600-39847000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr21:39846600-39847200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
44	chr21:39846600-39847600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr21:39846600-39847600	Enhancers	HUVEC	blood vessel
46	chr21:39846600-39849400	Weak transcription	Osteobl	bone
47	chr21:39846800-39847600	Enhancers	Adipose Nuclei	Adipose
48	chr21:39846800-39851400	Enhancers	Thymus	Thymus
49	chr21:39847000-39847200	Transcr. at gene 5' and 3'	Primary hematopoietic stem cells short term culture	blood
50	chr21:39847000-39847400	Enhancers	ES-WA7 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links